Oncology patients pose challenge in choosing birth control method.
Neinstein
L S
LS
Katz
B
B
D000028:Abortion, Induced; D000032:Abortion, Therapeutic; D000470:Alkaloids; D000554:Ambulatory Care Facilities; D000963:Antimetabolites; D001695:Biology; D055598:Chemical Phenomena; D002621:Chemistry; D009358:Congenital, Hereditary, and Neonatal Diseases and Abnormalities; D003267:Contraception; D003376:Counseling; D003710:Demography; D004194:Disease; D005193:Family Planning Services; D005313:Fetal Death; D005835:Genitalia; D005836:Genitalia, Female; D006285:Health Planning; D008660:Metabolism; D009026:Mortality; D009369:Neoplasms; D009930:Organic Chemicals; D009934:Organization and Administration; D010053:Ovary; D004364:Pharmaceutical Preparations; D010827:Physiology; D011153:Population; D011157:Population Dynamics; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012098:Reproduction; D013812:Therapeutics; D014566:Urogenital System
D000470:Alkaloids; D000963:Antimetabolites; D009930:Organic Chemicals; D004364:Pharmaceutical Preparations
Abortion, Induced--indications; Abortion, Therapeutic--indications; Alkaloids--side effects; Antimetabolites--side effects; Biology; Cancer; Clinic Activities; Contraception; Counseling; Demographic Factors; Diseases; Drugs--side effects; Family Planning; Fertility Control, Postconception--indications; Fetal Death; Genital Effects, Female; Genitalia; Genitalia, Female; Ingredients And Chemicals; Metabolic Effects; Mortality; Neonatal Diseases And Abnormalities; Neoplasms; Organic Chemicals--side effects; Organization And Administration; Ovarian Effects; Ovary; Physiology; Population; Population Dynamics; Pregnancy; Pregnancy, First Trimester; Program Activities; Programs; Reproduction; Treatment--side effects; Urogenital Effects; Urogenital System